US Approves Sativex Trials
US regulators (the Food and Drug Administration) have given UK company, GW Pharmaceuticals, approval to conduct a Phase III study into its cannabis extract Sativex as a treatment for cancer pain.
This is a significant achievement, since it waives the earlier-stage trials: nonetheless, it is unlikely that Sativex would be in the US marketplace until towards the end of the decade.
This acceptance of the possible benefit of cannabis is astonishing, when until recently federal prosecutions were being made against state-approved marijuana growers. In the case of one such grower, Ed Rosenthal, the judge would not allow the jury to be informed that his growing had been approved under Californian law. After the case, the jury were incensed at having been denied this knowledge of the defendant. Rightly so. In such a court what value is there in 'the truth, the whole truth and nothing but the truth'?
Here's a wealth of reading on US medical cannabis and the law.
Source: IACM-Bulletin of 8 January 2006.
This is a significant achievement, since it waives the earlier-stage trials: nonetheless, it is unlikely that Sativex would be in the US marketplace until towards the end of the decade.
This acceptance of the possible benefit of cannabis is astonishing, when until recently federal prosecutions were being made against state-approved marijuana growers. In the case of one such grower, Ed Rosenthal, the judge would not allow the jury to be informed that his growing had been approved under Californian law. After the case, the jury were incensed at having been denied this knowledge of the defendant. Rightly so. In such a court what value is there in 'the truth, the whole truth and nothing but the truth'?
Here's a wealth of reading on US medical cannabis and the law.
Source: IACM-Bulletin of 8 January 2006.
posted by deCinabre at 2:16 PM
0 Comments:
Post a Comment
<< Home